Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-22-000123 General Corporate
Debt relative to revenue 33th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.debt_to_revenue
320.50% · OPTIONAL · VALID
Capex intensity 44th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.09% · OPTIONAL · VALID
Operating cash generation 81th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
36.13% · OPTIONAL · VALID
Revenue growth 36th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
54.24% · CORE · VALID
Gross margin 56th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
78.43% · CORE · VALID
Operating margin 61th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
-19.43% · CORE · VALID
R&D intensity 39th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.08% · OPTIONAL · VALID
SBC intensity 56th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
29.58% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 88.79%
Current 320.50%
Delta 231.71% Capex Intensity Increased
Previous 6.35%
Current 7.09%
Delta 0.74% Cash Generation Increased
Previous 29.51%
Current 36.13%
Delta 6.62% Growth Decreased
Previous 62.08%
Current 54.24%
Delta -7.84% Margin Increased
Previous 77.79%
Current 78.43%
Delta 0.64% Profitability Increased
Previous -30.01%
Current -19.43%
Delta 10.58% R And D Intensity Decreased
Previous 26.50%
Current 21.08%
Delta -5.42% Sbc Intensity Decreased
Previous 37.54%
Current 29.58%
Delta -7.96% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.